Aim: to assess cognitive function in elderly subjects with clinically probable Parkinson's disease (PD). Methods: a community sample of 126 patients with probable PD completed the CAMCOG, which is the cognitive section of the Cambridge Examination for Mental Disorders, and the Mini-Mental State Examination (MMSE). The performance of the CAMCOG and the MMSE in detecting dementia in this subject group was compared with the results of applying the DSM-IV criteria for dementia to this population. Results: A total of 44% of the group met DSM-IV criteria for dementia, which is higher than most previous prevalence figures for dementia in PD. The CAMCOG was more sensitive than the MMSE in detecting cognitive impairment and more specific than the MMSE in detecting dementia as defined by DSM-IV criteria. Poorer performance on the CAMCOG was related to gender, social class and age (P < 0.05). Among subjects with PD, those with dementia, as defined by DSM-IV criteria, were significantly older, had greater depressive symptomatology and had greater motor deficits. A greater proportion of the group with dementia were living in residential care (P < 0.05).
Introduction
Dementia is common in older patients with Parkinson's disease (PD), although prevalence figures of clinical and population studies vary between 4% and 93% [1] [2] . Two recent population-based studies have found prevalence rates of dementia in PD of at least 40% [3, 4] . Studies of the incidence of dementia in PD suggest a risk of at least twice that of age-matched subjects without the disease [5, 6] .
There is a need for a concise yet comprehensive neuropsychological screening test for cognitive impairment in PD to identify dementia and those at risk of developing dementia. Formal neuropsychological tests are detailed, but often require specialist training to administer and interpret and are often too timeconsuming for population-based studies. However, the CAMCOG (the cognitive section of the Cambridge Examination for Mental Disorders) is a brief, comprehensive and easy to administer test of cognitive function which was designed for use in older subjects and appears well-suited as a screening tool in PD [7, 8] . The CAMCOG includes eight subscales of cognitive assessment: orientation, language, memory, attention, praxis, calculation and perception. Brief standardized tests, such as the 10-item Hodkinson Mental test [9] , the Clifton Assessment Procedure for the Elderly assessment scale [10] and the Mini-Mental State Examination (MMSE) [11] , tend to be heavily languagedependent. They also demonstrate floor effects in subjects with severe cognitive impairment and ceiling effects in subjects with mild impairment. Despite this, the MMSE has been widely used to screen elderly individuals for dementia [10, 11] .
The most widely used clinical criteria for dementia are contained in the fourth edition of the American Psychiatric Association's Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) [12] . Diseasespecific criteria for dementia in PD-the Cummings and Benson criteria-involve the use of a battery of extensive neuropsychological procedures to produce a classification of dementia severity [13] .
We have used the CAMCOG and the MMSE to screen for dementia and cognitive impairment in a group of community-dwelling elderly subjects with clinically probable PD. The results from using these two measures were compared with the outcome of applying the clinical DSM-IV criteria for dementia to the same group.
Methods
Subjects over the age of 60 years old and living at home and in institutions were recruited from an on-going epidemiological study of PD in North Wales. Subjects were identified on the basis of receipt from general practitioner of drugs used to treat PD. All general practitioners in the study area had computerized prescribing systems. All subjects ascertained by this means and living in a defined geographical area were visited at home, where a neurological history was taken and examination performed. Subjects meeting clinical diagnostic criteria for probable PD [14] were invited to take part in this study and underwent further assessment. Those with drug-induced PD or other forms of parkinsonism were excluded.
Individuals were screened with the CAMCOG and the MMSE test. One item (recognition of person/ function) was omitted from the original 107-item CAMCOG as it was originally intended for hospital populations and therefore unsuitable for a community sample. The possible maximum CAMCOG score in this study was 106. Subjects were considered to screen positively for dementia if their CAMCOG score was Յ80 [7] or if the score on the MMSE was Յ24 out of a possible score of 30 [11] . The severity of motor deficits in PD was measured using the Webster scale [15] . Educational level was determined by the age at which the subject left school and social class was determined by using the Registrar General's classification. All subjects were screened for symptoms of depression with the 15-item Geriatric Depression Scale [16] .
The DSM-IV criteria for dementia were applied to this group either at a clinic or their own home by an observer (R.J.M.) who was blind to the CAMCOG and MMSE results. Clinical diagnosis was made informally, based on historical information and available medical records. No formal cognitive testing was employed. Attempts were made to allow for the potential confounding effect of using DSM-IV in PD of motor, rather than cognitive disability, contributing to social and occupational impairment [17] .
Results were analysed by the SPSS software package using descriptive statistical tests, ANOVAs and nonparametric Wilcoxon t-tests.
Results
A total of 129 subjects with clinically probable PD on active drug treatment was ascertained in the area of the study. Three subjects declined to take part. The demographic profiles, performance on the CAMCOG and MMSE and clinical data for all 126 subjects are shown in Tables 1 and 2 .
Of the 126 subjects, 56 (44%) met the DSM-IV criteria for dementia. Employing the CAMCOG cut-off value of Յ80 resulted in 57 (47%) subjects screening positively for the presence of dementia. Compared with DSM-IV criteria, the CAMCOG misclassified four subjects as having and three as not having dementia. Poor educational background in one subject rather than dementia explained the poor performance on the CAMCOG. The CAMCOG had a sensitivity and specificity of 95% and 94% in detecting dementia compared with DSM-IV criteria. Using the MMSE at a cut-off of 23/ 24, 71 (55%) of subjects with PD screened positive for dementia. Compared with the DSM-IV criteria, the MMSE had a sensitivity of 98% and a specificity of 77% for dementia. Lowering the cut-off point of the MMSE will improve its specificity, although the reduction in sensitivity would be unacceptable for a screening tool. The scores from the CAMCOG ranged from 20 to 101, with a mean score of 80 (SD = 14) . No subject obtained the maximum CAMCOG score of 106 and only one subject scored above 100. By comparison, important ceiling effects were observed with the MMSE, where approximately 16% of the subjects scored maximum or near maximum scores of 29/30. Scores on the MMSE ranged from 5 to 30, with a mean of 24 (SD = 4). The CAMCOG scores in subjects who scored Ն29 on the MMSE ranged from 82 to 101, indicating that even at high levels of functioning, as indicated by the score on the MMSE, cognitive impairments were evident using the CAMCOG.
The results for the demented and non-demented PD groups are summarized in Table 3 . In all eight subscales of the CAMCOG significant differences were observed (P < 0.001) between the non-demented and demented groups. A summary and comparison of the CAMCOG subscales are presented in Table 4 . An ANOVA between the subscales of the CAMCOG revealed significant interaction between age and poor performance on five of the subscales (language, memory, attention, calculation, perception: P < 0.05). Differences with gender were also observed in two subscales (attention, calculation: P < 0.05), with men performing better than women). Performance also reflected social class (praxis, abstract thinking: P < 0.05), with higher scores recorded for the professional/managerial classes and the skilled non-manual classes than the manual unskilled classes. Although no significant differences in performance on the CAMCOG were observed in relation to the level of educational attainment in the group as a whole, trends in the data suggest that lower educational achievement was associated with poorer performance on the CAMCOG.
A non-parametric t-test comparison of the demented and non-demented PD groups revealed that the demented PD group were older (P < 0.001), had higher levels of depressive symptomatology (P < 0.014) and had more severe motor deficits as measured on the Webster scale (P < 0.001). More subjects in the demented PD group were cared for in residential accommodation (P < 0.001) and fewer in this group were living alone at home at the time of the study (P < 0.001).
Discussion
The crude prevalence ratio for dementia in people with PD over the age of 60, based on DSM-IV criteria, was 44%. This is similar to that reported previously from community-based studies [3, 4] , but is higher than that found in hospital-based studies. Referral bias would tend to reduce the prevalence of dementia in hospitalbased clinic populations. Several factors would have influenced the prevalence ratio for dementia found in this study. The study population lived in a retirement area and, since dementia in PD is strongly linked to age [1] , this would have partly accounted for the high prevalence. Subjects with mild PD who were not on drug therapy and therefore not ascertained in the study would also have reduced the prevalence ratio for dementia. However, subjects with PD living in institutional care, who are likely to be cognitively impaired [18] , may be underrepresented in the community register because of difficulty in contacting them and obtaining consent. Furthermore, subjects in whom drug treatment had been withdrawn due to neuropsychiatric side-effects or not commenced because of established dementia, would have increased the prevalence of dementia. Lastly, some prevalent cases of PD in elderly subjects may be clinically symptomatic but medically undiagnosed [19] . Overall, it is likely that the prevalence of dementia in the study population is an underestimate. Diagnostic accuracy for PD in this study, despite using agreed clinical criteria, is likely to be around 80%. Cases of parkinsonism not due to PD are more likely than PD to be associated with dementia. Dementia can arise from several causes in PD, but this was not investigated in this study [20] .
Both screening measures had a high sensitivity for dementia in PD as defined by the clinical DSM-IV criteria for dementia. However, the specificity of the CAMCOG was markedly greater than that of the MMSE. A high false-positive rate for dementia in elderly subjects using the MMSE has been reported [21] . Compared with the CAMCOG in this study, the MMSE also demonstrated considerable ceiling effects. A recent community-based study of elderly subjects which employed both measures similarly found that 17% of their sample had MMSE scores of Ն29, whereas the CAMCOG scores for the same subjects ranged from 80 to 102 [22] . It could be argued that the ability of the CAMCOG to define a group of subjects with PD and cognitive impairment falling short of dementia indicates that it is an appropriate tool with which to study the development and progression of cognitive impairment in PD. PD subjects with cognitive impairment will be vulnerable to adverse reactions from their drugs with subsequent risk of institutional care. A limiting factor of the CAMCOG may be the time it takes to complete. In the present study each assessment took, on average, 25 min.
As with many neuropsychological procedures, interpretation of the performance on the CAMCOG must take into account factors such as age, social class and educational attainment. In this study, increasing age was associated with poorer performance on the CAMCOG, which is a commonly-reported feature in studies that screen for cognitive impairments in elderly subjects [23, 24] . Performance was also influenced by social class and education.
PD subjects with dementia tended to have more severe motor impairment and also higher levels of depression than those who are not demented. A relationship between motor severity [25] [26] [27] [28] [29] and depression [26, 30, 31] has been demonstrated in other studies of dementia in PD. Depression is common in PD [32, 33] and it is possible that depression may coexist with dementia rather than exert a negative effect upon it. Marked depressive symptoms were also present in over half of the non-demented group in our study. A recent report which examined cognitive function in patients with post-stroke depression found that even when mood symptoms resolved, cognitive function did not significantly improve [34] . A limitation of this study is the use of a self-report measure of depressive symptomatology as subjects with more severe cognitive impairments may not have accurately reported their symptoms.
This study, using standardized criteria for PD and for dementia, suggests that the prevalence of dementia in community-dwelling elderly subjects with PD has been underestimated in previous reports. However, the lack of standardized prevalence data on dementia in PD makes the interpretation of crude and age-specific prevalence rates difficult. This study also demonstrates that the CAMCOG can achieve satisfactory levels of sensitivity and specificity for detecting dementia in elderly subjects with PD. Furthermore, the CAMCOG appears to be useful in the follow-up of subjects with cognitive impairment who may be at risk of developing dementia.
Key points
• The CAMCOG is a more sensitive and specific measure of cognitive impairment in Parkinson's disease than the Mini-Mental State Examination.
• Employing the CAMCOG may assist in the detection of those who are at risk of becoming demented.
• The prevalence of dementia and cognitive problems in elderly patients with Parkinson's disease may be underestimated.
